Atropine Sulphate 0.6mg/mL Injection

Atropine Sulphate 0.6mg/mL Injection is an injectable anticholinergic medicine used in monitored medical settings. It is used for bradycardia where raising the heart rate is clinically needed, as pre-anaesthetic medication to reduce secretions in selected cases, as part of reversal plans for some muscle-relaxant regimens, and as an antidote in certain organophosphate or cholinergic poisoning situations. Atropine blocks acetylcholine at muscarinic receptors, which increases heart rate and reduces secretions from glands. This same action can also cause dry mouth, blurred vision, light sensitivity, fast heartbeat, urinary retention, constipation, reduced sweating, confusion, or overheating. Caution is especially important in glaucoma risk, urinary retention, prostate enlargement, bowel obstruction, heart disease, high thyroid activity, fever, and older adults.
Atropine Sulphate 0.6mg/mL Injection is given by a doctor or nurse by IV, IM, or subcutaneous route depending on the emergency or perioperative indication. Monitoring may include heart rate, blood pressure, temperature, mental status, breathing, and response to antidote or anaesthesia care. Do not self-administer.
Atropine blocks muscarinic acetylcholine receptors. This reduces parasympathetic effects, raises slow heart rate, dries secretions, relaxes some smooth-muscle spasm, and counters muscarinic effects of certain poisonings.
Possible effects include dry mouth, blurred vision, dilated pupils, fast heartbeat, nausea, vomiting, constipation, urinary difficulty, reduced sweating, flushing, fever, dizziness, and confusion. Serious concerns include severe fast rhythm, worsening glaucoma, urinary retention, overheating, agitation, hallucinations, seizures, or severe allergic reaction.
Avoid unsupervised use. Caution is needed in narrow-angle glaucoma, urinary retention, prostate enlargement, severe heart disease, arrhythmia, high blood pressure, hyperthyroidism, bowel obstruction, fever, pregnancy, breastfeeding, and older adults. Heat exposure can be risky because sweating may be reduced.
Can rapidly increase dangerously slow heart rate, reduce secretions during selected procedures, and counter muscarinic toxicity in specific poisoning emergencies.
Atropine Sulphate 0.6mg/mL Injection is used for bradycardia, selected anaesthesia uses, and certain poisoning or reversal situations under medical supervision.
No. It requires dose selection and monitoring by healthcare staff.
Atropine blocks muscarinic acetylcholine effects, reducing secretions and affecting pupil and focusing responses.
People with glaucoma risk, urinary retention, prostate enlargement, bowel obstruction, heart disease, hyperthyroidism, fever, or older age need caution.
Severe agitation, confusion, hallucinations, high fever, very fast heartbeat, urinary retention, or seizures need urgent care.
Atropine sulphate, Bradycardia medicine, Anticholinergic, Organophosphate antidote, Anaesthesia secretion reduction, Slow heart rate treatment, AR: Atropine Sulphate /mL حقن, FR: Atropine Sulphate /mL, PT: Atropine Sulphate /mL injeção, ES: Atropine Sulphate /mL inyección, RU: Atropine Sulphate /mL инъекция, ID: Atropine Sulphate /mL injeksi, VI: Atropine Sulphate /mL thuốc tiêm, MS: Atropine Sulphate /mL suntikan, TL: Atropine Sulphate /mL iniksyon, ZH-SG: Atropine Sulphate /mL 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Atropine Sulphate 0.6mg/mL Injection under Anaesthesia Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Atropine Sulphate 0.6mg/mL Injection